Work

NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor—Positive Breast Cancer

Year: 2006

Type: article

Source: Clinical Breast Cancer

DOI: 10.3816/cbc.2006.n.061

Authors: Eleftherios P. Mamounas, Barry Lembersky, Jong-Hyeon Jeong, Walter Cronin, Barbara Harkins, Charles Geyer, Donald Lawrence Wickerham, Soonmyung Paik, Joseph Costantino, Norman Wolmark

Institutions: Aultman Health Foundation, University of Pittsburgh, NSABP Foundation, Allegheny General Hospital

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Health and Human Services, National Cancer Institute

Awards: G15472828, G2469740015, Biostatistical Center for the NSABP, NSABP COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE - OPERATIONS CENTER, Clinical Oncology Program Biostatistical Center, G742888810, NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT, G979864291

OpenAlex ID: W2013094952

FWCI: 1.698

Cites: 40

Cited by: 37

Related to: 10